share_log

Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery

Surgalignは、脊椎手術用の世界初のAI駆動型ARガイダンスシステムであるHOLOポータルシステムのFDA認可を受けています

Benzinga Real-time News ·  2022/01/18 06:32

Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has received U.S. Food & Drug Administration (FDA) 510(k) clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures. The HOLO Portal system is the world's first artificial intelligence (AI)-driven augmented reality (AR) guidance system for spine and the first clinical application of Surgalign's HOLOTM AI digital health platform.

"Receiving the initial clearance for the HOLO Portal system is a significant milestone and represents a...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする